全文获取类型
收费全文 | 5621篇 |
免费 | 580篇 |
国内免费 | 4篇 |
出版年
2021年 | 62篇 |
2019年 | 56篇 |
2018年 | 54篇 |
2017年 | 49篇 |
2016年 | 93篇 |
2015年 | 134篇 |
2014年 | 182篇 |
2013年 | 206篇 |
2012年 | 280篇 |
2011年 | 277篇 |
2010年 | 187篇 |
2009年 | 167篇 |
2008年 | 238篇 |
2007年 | 242篇 |
2006年 | 232篇 |
2005年 | 239篇 |
2004年 | 281篇 |
2003年 | 228篇 |
2002年 | 246篇 |
2001年 | 116篇 |
2000年 | 106篇 |
1999年 | 111篇 |
1998年 | 72篇 |
1997年 | 75篇 |
1996年 | 68篇 |
1995年 | 60篇 |
1994年 | 60篇 |
1993年 | 65篇 |
1992年 | 93篇 |
1991年 | 92篇 |
1990年 | 109篇 |
1989年 | 99篇 |
1988年 | 91篇 |
1987年 | 99篇 |
1986年 | 84篇 |
1985年 | 115篇 |
1984年 | 82篇 |
1983年 | 71篇 |
1982年 | 69篇 |
1981年 | 91篇 |
1980年 | 65篇 |
1979年 | 68篇 |
1978年 | 62篇 |
1977年 | 68篇 |
1976年 | 66篇 |
1975年 | 58篇 |
1974年 | 69篇 |
1973年 | 52篇 |
1972年 | 52篇 |
1969年 | 43篇 |
排序方式: 共有6205条查询结果,搜索用时 328 毫秒
1.
Conventional therapies for prostate cancer, especially in its androgen-independent form, may result in the survival of small populations of resistant cells with tumor-initiating potential. These “cancer stem cells” are believed to be responsible for cancer relapse, and therapeutic strategies targeting these cells are of great importance. Telomerase is a ribonucleoprotein enzyme responsible for telomere elongation and is activated in the majority of malignancies, including prostate cancer, but is absent in most normal cells. Putative tumor-initiating cells have significant levels of telomerase, indicating that they are an excellent target for telomerase inhibition therapy. In this review, we present some evidence for the hypothesis that conventional therapies (standard chemotherapy and/or radiation therapy) in combination with telomerase inhibitors may result in effective and more durable responses. 相似文献
2.
A hitherto unknown defect in the immune responsiveness of B lymphocytes from SJL mice has enabled us to distinguish two qualitatively distinct classes of signal delivered to B cells by C8-substituted guanine ribonucleosides. This defect renders B cells from SJL mice unresponsive to the inductive (early acting) signal of 8-mercaptoguanosine (8MGuo) that culminates in mitogenesis and nonspecific secretion of immunoglobulin. Unresponsiveness is not attributable to a shift in either the dose-response or kinetic profiles, nor can the presence of suppressor cells be demonstrated. In striking contrast, however, SJL B cells exhibit normal responsiveness to the differentiative (T cell-like, or late acting) signal provided by the substituted nucleoside. This signal enables SJL B cells, depleted of T cells, to respond to T cell-dependent antigens, and synergizes with T cell-derived lymphokines. These data suggest 1) that nonspecific secretion of immunoglobulin is dependent on both inductive and differentiative signals, 2) that antigen alone can supply an effective inductive signal for antigen-specific responses, and 3) that the SJL mouse will provide a useful model for selective study of inductive vs differentiative events. 相似文献
3.
4.
5.
6.
Substratum topography and cell traction on sulphuric acid treated bacteriological-grade plastic 总被引:1,自引:0,他引:1
Treatment of bacteriological-grade plastic with concentrated sulphuric acid is a well known technique which increases the wettability of the surface and renders it suitable for eukaryotic cell adhesion. We have noticed that these substrata present a distinctive surface topography in the presence of a serum supplement under normal culture conditions. The adsorbed serum layer is comprised of fine furrows and ridges and the influence of adherent cells on this layer leads to minute tears and distortions in the direction of the corrugations. This provides a novel system for the investigation of cell spreading and locomotion by scanning electron microscopy. 相似文献
7.
8.
9.
10.
Vinyl chloride (VC) is used as an example to demonstrate how biological information can be incorporated into quantitative risk assessment. The information included is the pharmacokinetics of VC in animals and humans and the data-generated hypothesis that VC primarily affects the initiation stage of the multistage carcinogenesis. The emphasis in this paper is on the improvement of risk assessment methodology rather than the risk assessment of VC per se.Sufficient data are available to construct physiologically-based pharmacokinetic models for both animals and humans. These models are used to calculate the metabolized dose corresponding to exposure scenarios in animals and in humans.On the basis of the data on liver angiosarcomas and carcinomas in rats, the cancer risk per unit of metabolized dose is comparable, irrespective of routes (oral or inhalation) of exposure. The tumor response from an intermittent/partial lifetime exposure is shown to be consistent with that from a lifetime exposure when VC is assumed to affect the first (initiation) stage of the multistage carcinogenic process. Furthermore, the risk estimates calculated on the basis of animal data are shown to be consistent with the human experience. 相似文献